FD
SEC Insider//CIK 0001164007
FRANK DANIEL
CIK 00011640072 companiesNEW YORK, NY
Transactions
17
Companies
2
Filings
10
CIK
0001164007
Recent Transactions
- Award
- Will/Inheritance
- Award
- Award
- Conversion
Common Stock, par value $0.01 per share
2007-02-01+72,120→ 72,120 total - Conversion
Series C Convertible Preferred Stock
2007-02-01−1,488→ 0 total - Conversion
Common Stock Purchase Warrant (right to buy)
2007-02-01$3.96/sh−12,626→ 0 total - Conversion
Series B Convertible Preferred Stock
2007-02-01−1,894→ 0 total - Conversion
Common Stock, par value $0.01 per share
2007-02-01+12,626→ 139,113 total - Conversion
Common Stock, par value $0.01 per share
2007-02-01+54,367→ 126,487 total - Disposition from Tender
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
- Purchase
Companies
2Recent Filings
10- 4
FRANK DANIEL
May 17, 2010
- 5
FRANK DANIEL
Feb 16, 2010
- 4
FRANK DANIEL
May 14, 2009
- 4
Molecular Insight Pharmaceuticals, Inc.
Jun 28, 2007
- 4
Molecular Insight Pharmaceuticals, Inc.
Feb 5, 2007
- 4
FRANK DANIEL
Feb 10, 2004
- 4
I STAT CORPORATION /DE/
Aug 7, 2002
- 4
I STAT CORPORATION /DE/
Aug 7, 2002
- 4
FRANK DANIEL
Jun 4, 2002
- 4
FRANK DANIEL
Mar 1, 2002
Address
C/O CERBERUS CAPITAL MANAGEMENT, L.P. 299 PARK AVENUE, 22ND FLOOR
NEW YORK, NY, 10171